D.A.A.6 XPLODE - D-Aspartic Acid Complex.
Warning: Last items in stock!
D.A.A.6 Xplode from Beverly Nutrition is a compound with high concentrations of D - aspartic acid an amino acid capable of increasing testosterone levels naturally and safely. D.A.A.6 Xplode has proven to be very safe and effective to increase testosterone levels naturally by up to 50 % noting its powerful effects in just a few days.
D.A.A.6 Xplode plays an important role in the release of luteinizing hormone (LH), growth hormone (GH ) and nervous system function , up to 50% by increasing testosterone levels in the body in a complete natural , fast and safe way.
D.A.A.6 Xplode provokes a great impact, more than 200% increase in strength, power , energy and muscle growth without adding even a single gram of fat, creating new muscle cells free of fatty tissue , that is, dry large rocky muscle.
D.A.A.6 Xplode also contains Tongkat Ali extract which produces a significant increase in muscle especially in men , this compound will produce an additional 5% increase in body mass acting at the same time as a potent fat burner . Tongkat Ali is more powerful than herb tribulus terrrestis which takes years to mature. The full development is achieved in 25 years hence its powerful benefits.
D.A.A.6 Xplode Benefits
• Increase strength
• Increase in muscle mass
• Increase power and energy
• Feeling of well-being
• Increase of libido improving sexual life .
• Acts as a powerful fat burner
Bottle with 120 cas
Products reviewed here are food supplements or as established by European Directive 2002/46/EC on food supplements and all can be legally sold in all countries of the European Community, under Articles 28, 29 and 30 of the treaty the European Community and by Articles 1 to 4 of the European Parliament Decision 3052/95/EC number. Dietary supplements are not trying to replace a balanced and varied diet, are presented only in order to supplement the intake of nutrients of a normal diet. Neither treat, prevent, diagnose or cure any disease, acts attributable to drugs, as defined by European Directive 2004/27/EC of 31 March, the Council and European Parliament on medicinal products.